Trademark: 90639492
Word
WE SPEAK FLUENT LAB TO LIFE
Status
Dead
Status Code
606
Status Date
Monday, October 2, 2023
Serial Number
90639492
Mark Type
4000
Filing Date
Monday, April 12, 2021
Published for Opposition
Tuesday, January 4, 2022
Abandoned Date
Monday, October 2, 2023

Trademark Owner History
Syneos Health, LLC - Owner At Publication

Classifications
41 Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and providing podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and providing podcasts
35 Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
44 Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications
42 Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information

Trademark Events
Oct 2, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 2, 2023
Abandonment - No Use Statement Filed
Feb 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 31, 2023
Sou Extension 2 Granted
Jan 31, 2023
Sou Extension 2 Filed
Jan 31, 2023
Sou Teas Extension Received
Aug 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 4, 2022
Sou Extension 1 Granted
Aug 4, 2022
Sou Extension 1 Filed
Aug 4, 2022
Sou Teas Extension Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Nov 29, 2021
Approved For Pub - Principal Register
Nov 15, 2021
Assigned To Examiner
Jul 19, 2021
New Application Office Supplied Data Entered
Apr 15, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24